Pharmacogenomics Initiative
What is Pharmacogenomics ?
- the study of how genes affect an individual's response to drugs
- a revolutionary change in medicine to individualized patient care
- uses markers in the genetic code of an individual to pinpoint the bases of disease and design a ratioanle drug treatment regimen
Components of a Center of Excellence in Pharmacogenomics
USF/James Haley VA Pharmacogenomics Laboratory
- currently processes 25,000 samples/day
- current genotyping analyses: HIV, HCV, Factor II, Factor V Leiden, CYP2D9
- uses markers in the genetic code of an individual to pinpoint the bases of disease and design a ratioanle drug treatment regimen
Presentation
Contact Information
Dr. Lynn Wecker, Associate Dean for Research
USF College fo Medicine
MDC Box 61
Phone: (813) 974-3823
Email: lwecker@health.usf.edu
USF College fo Medicine
MDC Box 61
Phone: (813) 974-3823
Email: lwecker@health.usf.edu
Allergy, Immunology and Infectious Diseases Cancer Biology Cardiovascular Research Neuroscience Research
New Collaborative
Emerging Areas
of Interest
of Interest
Biomedical Engineering Nanomedicine Neuromusculoskeletal Disorders(NEW) Pharmacogenomics Regenerative Medicine Sports Medicine Women's Health
COM Approved
Centers/Institutes
Centers/Institutes
Archie A. & Mary-Louise Silver Child Development Center Byrd Alzheimer’s Institute Cardiac Hormone Center Center for Aging & Brain Repair Center for Hospice, Palliative Care & End of Life Studies Diabetes Center Florida Infectious Disease Cente Institute for Research In Psychiatry and NeurosciencesJoy McCann Culverhouse Center for Swallowing Disorders Nanomedicine Research Center Pediatrics Epidemiology Center Suncoast Alzheimer's Clinic USF Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence